Key rules and limits in making obesity and metabolism policies in Asian health systems

Obesity is associated with metabolic syndrome and cardiometabolic disease in Asia at lower levels of body fat compared to Western populations.

• Asian populations may experience complications from obesity at lower body fat levels than those in Western populations.
• A review of obesity policies in Asia highlights design features that may enhance their long-term effectiveness.
• Access to incretin-based medications is considered within the context of these obesity policies.

Simplified